Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Insulin-like growth factor I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses' Health Study II
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor?
Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk.
A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers.
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3.
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 3
A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis.
A Pilot Trial of Oral Melatonin Supplementation in Breast Cancer Survivors
Insulin Like Growth Factor Binding Protein 2